Loading organizations...
Key people at Yali Capital.
Yali Capital operates as a venture capital firm specializing in early-stage deep technology investments. The firm focuses on companies innovating across critical sectors such as semiconductors, robotics, genomics, aerospace, and artificial intelligence. Their investment strategy is distinguished by a commitment to supporting ventures with foundational technological advancements, complemented by a team possessing extensive operational and scientific expertise.
The firm was founded in 2023, primarily by Ganapathy Subramaniam and Mathew Cyriac. Subramaniam, drawing on his background as a former partner at Celesta Capital, and Cyriac, with prior experience as co-head of private equity for Blackstone India, identified a significant need for specialized capital and guidance within the Indian deep tech ecosystem. Their shared conviction was that successful deep tech ventures require investors with a profound understanding of technical complexities and hands-on operational acumen.
Yali Capital primarily serves early-stage deep tech startups, partnering with founders who are developing complex intellectual property to address challenging problems. The firm’s overarching vision is to cultivate and strengthen the deep technology landscape by providing not only financial backing but also strategic and operational support. They aim to empower the next generation of innovators who are pushing the boundaries of scientific and engineering capabilities.
Key people at Yali Capital.
Yali Capital has 2 tracked investments across 2 companies. The latest tracked deal is $65.0M Seed in DeepLase in March 2026.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Mar 19, 2026 | DeepLase | $65.0M Seed | Mounttech, Yali Capital | — |
| Dec 1, 2020 | CANbridge Pharmaceuticals | $43.0M Series E | Cathy Chen | Casdin Capital, Hudson BAY Capital, Lyfe Capital, RA Capital Management, SPDB International, Summer Capital, Tigermed |